General Workshop Documents
Session One: Welcome, Keynote Address & Intern ational Leadership Award
Welcome and Overview — James L. Mulshine, MD, Rush University Medical Center
Welcome presentation slides
Keynote – AI-Enabled Chest CT Screening for Comprehensive Cardiovascular Disease, Lung Cancer & COPD Prevention
Morteza Naghavi , MD, Founder, HeartLung.AI
James L. Mulshine, MD, International Leadership Award – Presentation to Professor Matthijs Oudkerk, PhD, MD, University of Groningen and Institute for DiagNostic Accuracy (iDNA)
Session Two: Population Health – Infection, Inflammation, Cancer – The Pathology Behind the Images Being Analyzed by AI & Reported to Clinicians
Chair & Moderator: Albert Rizzo, MD, FCCP, FACP, FAASM, American Lung Association
Topic 1: Using Large, Longitudinal Databases to Predict Status Of Disease Processes
Moderator: George R. Washko, MMSc, MD, Brigham and Women’s Hospital and Harvard Medical School
Panelists:
R. Graham Barr, MD, DrPH, Columbia University
Elizabeth Estes, Open Source Imaging Consortium (OSIC)
View slides here
Simon Walsh, MD, PhD, National Lung and Heart Institute, Imperial College London (United Kingdom)
Lecia Sequist, MD, MPH, Massachusetts General Hospital and Harvard Medical School
View slides here
Topic 2: Infection, Inflammation, Cancer: The Pathology Behind the Imaging
Moderator: Javier J. Zulueta, MD, FCCP, Icahn School of Medicine at Mount Sinai
Panelists:
William L. Dahut, MD, American Cancer Society
Larry Schlesinger, MD, Texas Biomedical Research Institute
Steven M. Dubinett, MD, David Geffen School of Medicine, UCLA
Session Three: The Bright Future of Image Acquisition, Calibration & Artificial Intelligence
Chair & Moderator: Ricardo Avila, MS, Accumetra LLC
Moderator: Anthony P. Reeves, PhD, School of Electrical and Computer Engineering, Cornell University
Topic 1: The Integration of Artificial Intelligence in CT Image Reconstruction
Topic Overview: Bruno De Man, PhD, MS, GE HealthCare
Panelists:
Andreu Badal, PhD, Center for Devices and Radiological Health, US Food and Drug Administration
Brian E. Nett, PhD, GE HealthCare Adam S. Wang, PhD, Stanford University
Topic 2: Opportunities to Advance CT Lung Measurements Using CT Calibration & Artificial Intelligence
Topic Overview: Ricardo Avila, MS, Accumetra LLC
View slides here
Panelists:
Matthijs Oudkerk, PhD, MD, MSc, University of Groningen and Institute for DiagNostic Accuracy (iDNA) (Netherlands)
Stephen Lam, MD, FRCPC, University of British Columbia (Canada)
View slides here
Artit Jirapatnakul, PhD, Icahn School of Medicine at Mount Sinai
Session Four: Optimizing Annual Lung Cancer Screening CT to Characterize Coronary Artery Calcification (CAC) Clinical Evolution
Co-Chairs & Moderators:
David Yankelevitz, MD, Icahn School of Medicine at Mount Sinai
Matthew Cham, MD, University of Washington Medical Center
View slides here
Moderator: Tochukwu (“Tochi”) M. Okwuosa, DO, FACC, FAHA, Rush University Medical Center
Topic 1: Clinical Optimization of Lung Cancer Screening CT For CAC Theragnostics
Topic Overview: Fay Y. Lin, MD, Icahn School of Medicine at Mount Sinai
View slides here
Topic 2: Reporting Non-Coronary Cardiac Findings in Lung Cancer Screening CT
Topic Overview: David Yankelevitz, MD, Icahn School of Medicine at Mount Sinai
Topic 3: Designing A Medicare Cardiac Controlled Observational Study
Topic Overview: David Yankelevitz, MD, Icahn School of Medicine at Mount Sinai
Fay Y. Lin, MD, Icahn School of Medicine at Mount Sinai
David J. Maron, MD, Stanford Prevention Research Center, Stanford Health Care
View slides here
Matthijs Oudkerk, PhD, MD, MSc, University of Groningen and Institute for DiagNostic Accuracy (iDNA) (Netherlands)
Bruce S. Pyenson, FSA, MAAA, Milliman, Inc.
Session Five: Population Health
Co-Chairs & Moderators:
Bruce S. Pyenson, FSA, MAAA, Milliman, Inc.
Anita McGlothlin, GO2 for Lung Cancer
Topic 1: Payer Quality Metrics for Lung Cancer Screening – What Progress Is Being Made On This Essential Tool?
Topic Introduction: Bruce S. Pyenson, FSA, MAAA, Milliman, Inc.
View slides here
Topic Overviews & Panelists:
Grace Glennon, MS, RD, National Committee for Quality Assurance
View slides here
David R. Nerenz, PhD, Henry Ford Health
View slides here
Topic 2: Why Is Cost-Sharing So Often Incorrectly Billed for Preventive Services?
Topic Introduction: Bruce S. Pyenson, FSA, MAAA, Milliman, Inc.
Topic Overviews & Panelists:
Anita McGlothlin, GO2 for Lung Cancer
View slides here
Susan E. Pantely, FSA, MAAA, Milliman, Inc.
Tia Sawhney, DrPH, FSA, MAAA, Teus Health LLC
View slides here
Breakout Sessions
In keeping with our Workshop structure, we initiate conversations that carry discussions from the presentations into a Breakout process. Often it allows a broader perspective as more and different disciplinary colleagues participate more casually in conversations about given topics. Given the hybrid nature of QIW, we have set aside time on both days for the Breakouts.
Clinical Breakout – Thoracic CT Results: How To Simply Communicate Voluminous Amounts of Information
Clinical Breakout session document
Clinical Breakout conclusion slides
Technical Breakout – Acquiring Screening Thoracic CT Information For Optimal QI Interrogation Of Tobacco-Injury
Technical Breakout session document
Technical Breakout conclusion slides
Combined Breakout Session: Results & Action Items